How many insider declarations has Norwegian Securities Trading Act. filed?

Norwegian Securities Trading Act. has filed 5 public insider declarations with Oslo Børs.

What is Norwegian Securities Trading Act.'s role?

Norwegian Securities Trading Act.'s reported role is not specified by the regulator across the filings.

Which companies does Norwegian Securities Trading Act. report trades for?

Norwegian Securities Trading Act. reports trades for Lytix Biopharma ASA.

← Executives ★ Sign in to follow

NS

Norwegian Securities Trading Act.

·Oslo Børs

Lytix Biopharma ASA

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

Browse the full record of transactions filed by Norwegian Securities Trading Act.. Officer active across 1 company, notably Lytix Biopharma ASA. In total, 5 reports have been recorded. History available since 25 April 2024. The latest transaction was disclosed on 25 April 2024 (Subscription). Regulator: Oslo Børs. The full history is free.

Companies and markets linked to Norwegian Securities Trading Act.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Lytix Biopharma ASA (NO)

申报5 总计

●

Norwegian Securities Trading Act.

高管2024年12月27日（申报）Lytix Biopharma ASA

2Oslo ↗

ShareMERKOSLO:635698

●

Norwegian Securities Trading Act.

高管2024年12月17日（申报）Lytix Biopharma ASA

2Oslo ↗

ShareMERKOSLO:634985

●

Norwegian Securities Trading Act.

高管2024年12月17日（申报）Lytix Biopharma ASA

2Oslo ↗

ShareMERKOSLO:634909

●

Norwegian Securities Trading Act.

高管2024年4月26日（申报）Lytix Biopharma ASA

2Oslo ↗

@ €0.0085ShareMERKOSLO:617032

●

Norwegian Securities Trading Act.

高管2024年4月25日（申报）Lytix Biopharma ASA

NOK 380万10Oslo ↗

724,448 股@ NOK 5.24100.0% 占其流量ShareMERKOSLO:616907

5 条申报中的 5 条

InsidersTradesSigma

← Executives ★ Sign in to follow

NS

Norwegian Securities Trading Act.

·Oslo Børs

Lytix Biopharma ASA

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

Browse the full record of transactions filed by Norwegian Securities Trading Act.. Officer active across 1 company, notably Lytix Biopharma ASA. In total, 5 reports have been recorded. History available since 25 April 2024. The latest transaction was disclosed on 25 April 2024 (Subscription). Regulator: Oslo Børs. The full history is free.